Table 1 GI-RADS classification according to specific histopathologic diagnoses
Histopathology | GI-RADS | N | % | % of malignant | % benign | |||
|---|---|---|---|---|---|---|---|---|
2 | 3 | 4 | 5 | |||||
adenocarcinoma ovary | 0 | 2 | 36 | 6 | 44 | 20.5% | 83.0% | |
carcinoma papillare | 0 | 0 | 0 | 1 | 1 | 0.5% | 1.9% | |
cystadenofibroma serosum proliferans | 0 | 0 | 1 | 1 | 2 | 0.9% | 3.8% | |
cystadenoma mucinosum proliferans | 0 | 0 | 1 | 0 | 1 | 0.5% | 1.9% | |
cystadenoma proliferans | 0 | 1 | 3 | 1 | 5 | 2.3% | 9.4% | |
corpus luteum | 1 | 1 | 0 | 0 | 2 | 0.9% | 1.2% | |
corpus luteum hemorrhagicum | 0 | 1 | 1 | 0 | 2 | 0.9% | 1.2% | |
cystadenofibroma | 1 | 1 | 5 | 0 | 7 | 3.3% | 4.3% | |
cystadenofibroma mucinosum | 0 | 1 | 2 | 0 | 3 | 1.4% | 1.9% | |
cystadenofibroma serosum | 0 | 4 | 2 | 0 | 6 | 2.8% | 3.7% | |
cystadenoma mucinosum | 0 | 4 | 1 | 0 | 5 | 2.3% | 3.1% | |
cystadenoma serosum | 0 | 2 | 0 | 0 | 2 | 0.9% | 1.2% | |
cystis benigna | 0 | 0 | 1 | 0 | 1 | 0.5% | 0.6% | |
cystis follicularis | 0 | 2 | 1 | 0 | 3 | 1.4% | 1.9% | |
cystis lueinisans | 0 | 2 | 0 | 0 | 2 | 0.9% | 1.2% | |
cystis serosa | 0 | 16 | 6 | 0 | 22 | 10.2% | 13.6% | |
cystis serosa paraovarialis | 0 | 11 | 0 | 0 | 11 | 5.1% | 6.8% | |
cystis serosa paraoviducti | 0 | 1 | 0 | 0 | 1 | 0.5% | 0.6% | |
cystis serosum | 0 | 1 | 0 | 0 | 1 | 05% | 0.6% | |
cystis simplex | 0 | 3 | 0 | 0 | 3 | 1.4% | 1.9% | |
dermoidalna | 0 | 2 | 0 | 0 | 2 | 0.9% | 1.2% | |
endometrioma | 0 | 35 | 7 | 0 | 42 | 19.5% | 25.9% | |
fibrothecoma | 0 | 1 | 6 | 0 | 7 | 3.3% | 4.3% | |
folliculoma | 0 | 0 | 2 | 0 | 2 | 0.9% | 1.2% | |
hydrosalpinx | 0 | 1 | 1 | 0 | 2 | 0.9% | 1.2% | |
myoma pedunculated | 0 | 1 | 0 | 0 | 1 | 0.5% | 0.6% | |
ovarian abscess | 0 | 0 | 1 | 0 | 1 | 0.5% | 0.6% | |
teratoma | 0 | 25 | 9 | 0 | 34 | 15.8% | 21.0% | |
All | 2 | 118 | 86 | 9 | 215 | 100.0% | 100.0% | 100.0% |